A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/18 (2006.01) A61K 9/16 (2006.01) A61K 9/48 (2006.01) B01J 2/00 (2006.01) B29B 9/00 (2006.01)
Patent
CA 2415840
The invention relates to coated tamsulosin pellets and to unit dosage forms made therefrom. The invention provides a pharmaceutical dosage form comprising a plurality of pellets, wherein each pellet comprises: a. a pellet core having a diameter within the range of 0.3-0.9 mm and comprising a tamsulosin hydrochloride, microcrystalline cellulose, a pharmaceutically acceptable water permeable acrylic polymer and water; and b. an outer layer coat surrounding said core which comprises a pharmaceutically acceptable acid-resistant acrylic: polymer, wherein the mass of said outer layer coat, calculated on a dry pellet core basis, is within the range of 2.5-15%; and wherein the plurality of pellets exhibits a dissolution release profile in simulated gastric fluid using Ph. Eur. basket method at 100 rpm which includes releasing less than 100 of the tamsulosin during the first two hours. The invention also encompasses a process, which comprises: a. granulating a mixture of tamsulosin hydrochloride, microcrystalline cellulose, acrylic polymer, water and optionally auxiliary ingredients to form wet pellet cores, b. drying said wet pellet cores to a residual amount of water of 2-10%; c. sieving said dried pellet cores to obtain a fraction within the size range of 0.3-0.9 mm; d. coating said sieved dried pellet cores with a coating composition that comprises an acid-resistant water soluble acrylic polymer; and e. drying said coated pellet; wherein said coating step (d) is sufficient to provide said dried coated pellet with 2.5- 15 mass % of said coating composition, calculated on the dry pellet pore basis and a process, which comprises: (a) granulating a mixture of tamsulosin hydrochloride, microcrystalline cellulose, acrylic polymer, water and optionally auxiliary ingredients to form wet pellet cores, (b) drying said wet pellet cores to a residual amount of water of 2-10%; sieving said dried pellet cores to obtain a fraction within the sire range of: 0.3-0.9 mm; (c) coating said sieved dried pellet cares with a coating composition that comprises an acid-resistant water soluble acrylic polymer; (d) drying said coated pellet; (e) testing a sample of said dried coated pellets for dissolution rate in a simulated gastric fluid; and (f) repeating the coating process on the remaining dried coated pellets until a desired amount of release is achieved in said testing step (e).
Fetherstonhaugh & Co.
Synthon B.v.
LandOfFree
Pharmaceutical pellets comprising tamsulosin and a process... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical pellets comprising tamsulosin and a process..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical pellets comprising tamsulosin and a process... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1374986